These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23775012)

  • 41. CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.
    Brennan DJ; Jirstrom K; Kronblad A; Millikan RC; Landberg G; Duffy MJ; Rydén L; Gallagher WM; O'Brien SL
    Clin Cancer Res; 2006 Nov; 12(21):6421-31. PubMed ID: 17085655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
    Yu XW; Wu TY; Yi X; Ren WP; Zhou ZB; Sun YQ; Zhang CQ
    Tumour Biol; 2014 Jan; 35(1):155-60. PubMed ID: 23907576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Noxin promotes proliferation of breast cancer cells via P38-ATF2 signaling pathway.
    Zhang X; Zhang Y; Fan C; Wang L; Liu Y; Li A; Jiang G; Zhou H; Cai L; Miao Y
    Tumour Biol; 2017 Jun; 39(6):1010428317705515. PubMed ID: 28618963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer.
    Lindahl T; Landberg G; Ahlgren J; Nordgren H; Norberg T; Klaar S; Holmberg L; Bergh J
    Carcinogenesis; 2004 Mar; 25(3):375-80. PubMed ID: 14633656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast.
    Cheng CW; Liu YF; Yu JC; Wang HW; Ding SL; Hsiung CN; Hsu HM; Shieh JC; Wu PE; Shen CY
    Ann Surg Oncol; 2012 Dec; 19(13):4129-39. PubMed ID: 22864797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic significance of VEGF immunohistochemical expression in oral cancer: a meta-analysis of the literature.
    Zhao SF; Yang XD; Lu MX; Sun GW; Wang YX; Zhang YK; Pu YM; Tang EY
    Tumour Biol; 2013 Oct; 34(5):3165-71. PubMed ID: 23737289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of cyclin E isoforms correlates with poor prognosis in rectal cancer.
    Zhou YJ; Xie YT; Gu J; Yan L; Guan GX; Liu X
    Eur J Surg Oncol; 2011 Dec; 37(12):1078-84. PubMed ID: 21944050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
    Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
    Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CDK2 and cyclin E knockout mice: lessons from breast cancer.
    Lents NH; Baldassare JJ
    Trends Endocrinol Metab; 2004; 15(1):1-3. PubMed ID: 14693416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
    Qiao W; Liu H; Guo W; Li P; Deng M
    Eur J Surg Oncol; 2019 Jul; 45(7):1132-1137. PubMed ID: 30598194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is associated with poor outcome.
    Abramson VG; Troxel AB; Feldman M; Mies C; Wang Y; Sherman L; McNally S; Diehl A; Demichele A
    Anticancer Res; 2010 Apr; 30(4):1279-85. PubMed ID: 20530440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis.
    Zhu Y; Wu J; Zhang C; Sun S; Zhang J; Liu W; Huang J; Zhang Z
    Oncotarget; 2016 Oct; 7(43):70113-70127. PubMed ID: 27659521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elevated YKL-40 expression is associated with a poor prognosis in breast cancer patients.
    Wan G; Xiang L; Sun X; Wang X; Li H; Ge W; Cao F
    Oncotarget; 2017 Jan; 8(3):5382-5391. PubMed ID: 28036271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis.
    Baretta Z; Mocellin S; Goldin E; Olopade OI; Huo D
    Medicine (Baltimore); 2016 Oct; 95(40):e4975. PubMed ID: 27749552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of cyclin E messenger ribonucleic acid in nasopharyngeal carcinoma correlates with poor prognosis.
    Ko MT; Su CY; Huang SC; Chen CH; Hwang CF
    J Laryngol Otol; 2009 Sep; 123(9):1021-6. PubMed ID: 19275777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancers.
    Berglund P; Stighall M; Jirström K; Borgquist S; Sjölander A; Hedenfalk I; Landberg G
    Cancer Res; 2005 Nov; 65(21):9727-34. PubMed ID: 16266993
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of cyclin B1 and cyclin B2 expression in breast cancer: A systematic review and updated meta-analysis.
    Kang J; Jung H; Kim H
    Medicine (Baltimore); 2024 Jan; 103(3):e37016. PubMed ID: 38241547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma.
    Peng SY; Chou SP; Hsu HC
    J Hepatol; 1998 Aug; 29(2):281-9. PubMed ID: 9722210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of IGF-1R expression on the outcomes of patients with breast cancer: a meta-analysis.
    Yan S; Jiao X; Li K; Li W; Zou H
    Onco Targets Ther; 2015; 8():279-87. PubMed ID: 25674003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TP53 mutation is associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a meta-analysis.
    Zhan P; Ji YN; Yu LK
    Hepatobiliary Surg Nutr; 2013 Oct; 2(5):260-5. PubMed ID: 24570956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.